Authors
Latest:
Engaging Patients & Clinicians: Lessons from the PALM RegistryCase study evaluates the use of a mobile device tool for simplifying clinical trial patient enrollment and data collection.
Latest:
The ‘Pre’ Clinical Conversation: Dialogue Strategies UncoveredAudio study analyzes the communicative exchange factors between doctors and patients before enrollment-to better inform recruitment tactics.
Latest:
IRT Bridges Clinical and Supply Together—and Why It Matters4G Clinical head of marketing, Amy Ripston interviews Catherine Hall, director of operational excellence, at Sunovion to discuss how IRT bridges the gap between clinical and supply, and how interactive response technologies (IRT) can be leveraged to enable innovative trial designs.
Latest:
Six Steps to Ensuring Successful Clinical Trial ImagingAmit Vasanji, PhD and Brett A Hoover from ERT discuss technology and the steps to successful clinical trials.
Latest:
Leveraging Health IT to Improve Drug DevelopmentOutlining the ways FDA is adopting electronic practices and initiating efforts to simplify the submission process for new drug and generic drug applications.
Latest:
The Future Fit of Wearables for Patient-Centric Clinical TrialsHarnessing these tools for successful integration and streamlining of processes.
Latest:
Leveraging Health IT to Improve Drug DevelopmentOutlining the ways FDA is adopting electronic practices and initiating efforts to simplify the submission process for new drug and generic drug applications.
Latest:
The Success of Cell Therapies Will Depend on AutomationAutomation will be key to improving efficiency and mitigating risk during the complex process of cell therapy production and delivery.
Latest:
Anti-Microbial Resistance and the Role of VaccinesThis webcast will look at the scale of AMR, how CROs can assist in the development plan of new antimicrobials and where commercial development of new vaccines may be most effective. It will also provide insights and expert opinion on the potential success of antibacterial vaccination in controlling the rise of AMR and reducing the economic burden of infectious diseases. Live: North America: Thursday, Nov. 21, 2019 at 11am EST | 10am CST | 8am PST On demand available after airing until Nov. 21, 2020. Register free
Latest:
The Value of Empowered CRAs in Rare Disease StudiesExecutives from Atlantic Research Group discuss the importance of CRAs in rare disease clinical trials.
Latest:
Connecting Patients to Cutting-Edge CareHow can manufacturers ensure their clinical trial methods are evolving along with their product portfolio? It starts by taking a patient-focused approach to trial design, writes Susan Weidner.
Latest:
Unlocking the Potential of Risk-Based Quality MonitoringCOVID-19 may have accelerated the adoption of RBQM, but it is the intrinsic benefits that are cementing its continued use.
Latest:
The Case for Vendor Oversight for Small SponsorsExecutives from Edgerton Data Consulting and MedSurgPI discuss biopharmaceutical and medical device companies outsourcing one or more aspects of their clinical trials.
Latest:
The Case for Vendor Oversight for Small SponsorsExecutives from Edgerton Data Consulting and MedSurgPI discuss biopharmaceutical and medical device companies outsourcing one or more aspects of their clinical trials.
Latest:
The Case for Vendor Oversight for Small SponsorsExecutives from Edgerton Data Consulting and MedSurgPI discuss biopharmaceutical and medical device companies outsourcing one or more aspects of their clinical trials.
Latest:
The Importance of Biomarker ManagementExploring the benefits of capturing and integrating molecular biomarker data within clinical trials to build foundations for data assets.
Latest:
Increased Enrollment Efficiency With Point-of-Care Pre-ScreeningRetrospective analysis of clinical trial enrollment data evaluates the effectiveness of point-of-care testing in reducing later-screen failures.
Latest:
Increased Enrollment Efficiency With Point-of-Care Pre-ScreeningRetrospective analysis of clinical trial enrollment data evaluates the effectiveness of point-of-care testing in reducing later-screen failures.
Latest:
Increased Enrollment Efficiency With Point-of-Care Pre-ScreeningRetrospective analysis of clinical trial enrollment data evaluates the effectiveness of point-of-care testing in reducing later-screen failures.
Latest:
The PUEKS Project: Process Innovation in Clinical Trial MonitoringA look at the results of the recently completed project, which aimed to develop an holistic monitoring system via process integration to more effectively control clinical trial risks beyond isolated RBM strategies.
Latest:
The PUEKS Project: Process Innovation in Clinical Trial MonitoringA look at the results of the recently completed project, which aimed to develop an holistic monitoring system via process integration to more effectively control clinical trial risks beyond isolated RBM strategies.
Latest:
Unlocking the Potential of eClinical TechnologiesKey considerations for successful implementation in decentralized clinical trials.
Latest:
Improving Clinical Trial Delivery Times: Best PracticesFinalizing protocols, aligning teams, and staying engaged headline best practices.
Latest:
Clinical Trial TechnologyAlmac provides an overview of their clinical technologies branch, their IRT offerings, and the current changes to the clinical development industry.
Latest:
Rebadging Gains Momentum Amidst COVIDCapacity management and stability offer value for clients, their employees and FSP vendors.
Latest:
Rebadging Gains Momentum Amidst COVIDCapacity management and stability offer value for clients, their employees and FSP vendors.
Latest:
Functional Service Partnerships: A Case Study for CRO Resource ManagementA review of a recent FSP in which the CRO partner assumed clinical monitoring and site support responsibility for more than 50 ongoing trials.
Latest:
Making a Difference in Cancer Trials AccrualThe integration of pre-screening all patients for eligibility in oncology studies.
